Related Experiment Videos
[The shunt for portal hypertension in children]
Insights
Splenopneumopexy effectively controls esophageal varices bleeding in children with portal hypertension. This portopulmonary shunt procedure shows promise as a safe and effective treatment option.
Area of Science:
- Pediatric Surgery
- Hepatology
- Vascular Surgery
Context:
- Portal hypertension in children presents significant risks, including esophageal varices bleeding.
- Surgical shunt operations are employed to manage portal hypertension and its complications.
- Extrahepatic and intrahepatic lesions necessitate tailored surgical approaches.
Purpose:
- To evaluate the safety and efficacy of different shunt operations for pediatric portal hypertension.
- To assess the long-term outcomes of splenopneumopexy, mesocaval shunt, and splenorenal shunt in children.
- To determine the effectiveness of portopulmonary shunts in controlling esophageal varices hemorrhage.
Summary:
- Ten children with portal hypertension underwent shunt operations (9 extrahepatic, 1 intrahepatic).
- Splenopneumopexy (n=3) achieved hemorrhage control and demonstrated portopulmonary shunting.
- Mesocaval shunt (n=6) had mixed results with 3 non-recurrent bleeding cases and 2 deaths. Splenorenal shunt (n=1) in a child with hepatic cirrhosis resulted in non-recurrent bleeding.
Impact:
- Splenopneumopexy emerges as a potentially safe and effective surgical option for pediatric portal hypertension.
- The findings guide the selection of shunt procedures based on lesion type and patient outcomes.
- This study contributes to understanding surgical management strategies for complex pediatric liver disease.
Abstract:
Ten children with portal hypertension were treated with shunt operations. Among them, 9 were extrahepatic and one was intrahepatic lesion. The follow-up for 1-14 years showed: (1) In the 3 patients treated with splenopneumopexy, hemorrhage from the esophageal varices were controlled and portopulmonary shunt was demonstrated by Doppler ultrasound and radionuclide; (2) In the 6 patients treated with mesocaval shunt, 3 were non-recurrent bleeding and 2 died of recurrent bleeding or other disease respectively; (3) In one child with hepatic cirrhosis (11 year old) treated by splenorenal shunt, non-recurrent bleeding occurred. The authors suggest the portopulmonary shunt by splenopneumopexy is safe and effective for the portal hypertension of children.